These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8538238)

  • 1. Methotrexate for inflammatory bowel disease: pharmacology and preliminary results.
    Egan LJ; Sandborn WJ
    Mayo Clin Proc; 1996 Jan; 71(1):69-80. PubMed ID: 8538238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methotrexate in therapy of gastrointestinal diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1999 Jul; 37(7):623-37. PubMed ID: 10458012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose methotrexate in inflammatory bowel disease: current status and future directions.
    Schröder O; Stein J
    Am J Gastroenterol; 2003 Mar; 98(3):530-7. PubMed ID: 12650783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
    Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
    Vandell AG; DiPiro JT
    Pharmacotherapy; 2002 May; 22(5):613-20. PubMed ID: 12013360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving treatment strategies for inflammatory bowel disease.
    Hanauer SB; Dassopoulos T
    Annu Rev Med; 2001; 52():299-318. PubMed ID: 11160781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
    Temtem TA; Vickers M; Whitworth J
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.
    Fraser AG; Morton D; McGovern D; Travis S; Jewell DP
    Aliment Pharmacol Ther; 2002 Apr; 16(4):693-7. PubMed ID: 11929386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate.
    Egan LJ; Sandborn WJ; Mays DC; Tremaine WJ; Lipsky JJ
    Inflamm Bowel Dis; 1999 Aug; 5(3):167-73. PubMed ID: 10453372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.
    Hawthorne AB; Hawkey CJ
    Drugs; 1989 Aug; 38(2):267-88. PubMed ID: 2670519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice.
    Saibeni S; Bollani S; Losco A; Michielan A; Sostegni R; Devani M; Lupinacci G; Pirola L; Cucino C; Meucci G; Basilisco G; D'Incà R; Bruno S
    Dig Liver Dis; 2012 Feb; 44(2):123-7. PubMed ID: 22051323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Herfarth HH; Kappelman MD; Long MD; Isaacs KL
    Inflamm Bowel Dis; 2016 Jan; 22(1):224-33. PubMed ID: 26457382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
    Leung Y; Hanauer SB
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S202-8. PubMed ID: 20117343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
    Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006618. PubMed ID: 17943916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.